Pizzuti Dana

CIK 00019482381 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001948238

Recent Transactions

50 trades

Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-12-01$45.02/sh−5,000→ 66,837 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-12-01−5,000→ 69,042 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-12-01$16.89/sh+5,000→ 71,837 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-11-03$43.27/sh−100→ 66,270 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-11-03$42.65/sh−4,900→ 66,370 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-11-03$16.89/sh+5,000→ 71,270 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-11-03−5,000→ 74,042 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-10-01−5,000→ 79,042 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-10-01$16.89/sh+5,000→ 71,270 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-10-01$41.81/sh−5,000→ 66,270 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-09-02−5,000→ 84,042 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-09-02$16.89/sh+5,000→ 101,270 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-09-02$32.10/sh−5,000→ 96,270 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-08-22$30.43/sh−30,000→ 66,270 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-08-22−30,000→ 89,042 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-08-22$16.89/sh+30,000→ 96,270 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-08-20$29.18/sh−6,492→ 66,270 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-03-19$34.83/sh−127→ 72,233 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-03-19$34.17/sh−2,388→ 72,360 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-02-20+43,000→ 74,748 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-02-20+65,000→ 65,000 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-02-03$39.07/sh−5,000→ 31,748 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-02-03$16.89/sh+5,000→ 36,748 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2025-02-03−5,000→ 119,042 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (Right to Buy)
2025-01-07−2,500→ 18,500 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-01-07$19.64/sh+2,500→ 31,748 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2025-01-03−15,000→ 124,042 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-01-03$52.09/sh−15,000→ 29,248 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-01-03$16.89/sh+15,000→ 44,248 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-10-03$16.89/sh+14,375→ 42,882 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-10-03$54.63/sh−14,375→ 28,507 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2024-10-03−14,375→ 139,042 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-07-03$44.87/sh−14,375→ 28,507 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-07-03$16.89/sh+14,375→ 42,882 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2024-07-03−14,375→ 153,417 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-06-24$45.73/sh−9,500→ 27,786 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-06-24$16.89/sh+9,500→ 37,286 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2024-06-24−9,500→ 167,792 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-04-15$44.47/sh−14,375→ 27,786 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-04-15$16.89/sh+14,375→ 42,161 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock option (Right to Buy)
2024-04-15−14,375→ 177,292 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-03-20−10,000→ 191,667 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-03-20−4,375→ 201,667 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-20$16.89/sh+10,000→ 38,500 total
Exercise/Conversion
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-20$16.89/sh+4,375→ 32,875 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-20$43.69/sh−714→ 27,786 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-20$43.28/sh−10,000→ 28,500 total
Sale
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-20$45.89/sh−4,375→ 28,500 total
Tax Payment
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-18$38.14/sh−411→ 28,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-03-04+23,000→ 28,911 total

Companies

Crinetics Pharmaceuticals, Inc.
Chief Med and Dev Officer
$CRNX

Recent Filings

Address

C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD

SAN DIEGO, CA, 92121

View on SEC.gov